The microbiota–gut–brain Axis in psychiatric disorders

A Góralczyk-Bińkowska, D Szmajda-Krygier… - International journal of …, 2022 - mdpi.com
Modulating the gut microbiome and its influence on human health is the subject of intense
research. The gut microbiota could be associated not only with gastroenterological diseases …

The role of damage associated molecular pattern molecules (DAMPs) and permeability of the blood-brain barrier in depression and neuroinflammation

MF Serna-Rodríguez, S Bernal-Vega… - Journal of …, 2022 - Elsevier
Depression is a heterogeneous mental disorder characterized by feelings of sadness and
loss of interest that render the subject unable to handle basic daily activities such as …

LRFN5 and OLFM4 as novel potential biomarkers for major depressive disorder: a pilot study

K Xu, P Zheng, S Zhao, J Wang, J Feng, Y Ren… - Translational …, 2023 - nature.com
Evidences have shown that both LRFN5 and OLFM4 can regulate neural development and
synaptic function. Recent genome-wide association studies on major depressive disorder …

Circulating cell-free DNA levels in psychiatric diseases: a systematic review and meta-analysis

MM Melamud, VN Buneva, EA Ermakov - International Journal of …, 2023 - mdpi.com
The cell-free DNA (cfDNA) levels are known to increase in biological fluids in various
pathological conditions. However, the data on circulating cfDNA in severe psychiatric …

Plasma biomarkers in adolescents with schizophrenia‐spectrum disorder

P Zakowicz, M Skibińska, F Waśniewski… - Early Intervention in …, 2023 - Wiley Online Library
Aim Schizophrenia onset in the developmental age has a strong neurodevelopmental
burden and is associated with a poorer prognosis. The approach to diagnosis is still based …

Diminished treatment response in relapsed versus first-episode schizophrenia as revealed by a panel of blood-based biomarkers: A combined cross-sectional and …

H Cai, C Zeng, X Zhang, Y Liu, R Wu, W Guo, J Wang… - Psychiatry …, 2022 - Elsevier
There is a paucity of biomarkers for the prediction of treatment response in schizophrenia. In
this study, we aimed to investigate whether diminished antipsychotic treatment response in …

Bridging the gap: associations between gut microbiota and psychiatric disorders

GK Ahmed, HKA Ramadan, K Elbeh… - Middle East Current …, 2024 - Springer
Background Gut microbiota plays a pivotal role in the gut-brain axis and can influence
neurodevelopment and mental health outcomes. This review summarizes the current …

Correlations between omega-3 fatty acids and inflammatory/glial abnormalities: the involvement of the membrane and neurotransmitter dysfunction in schizophrenia

Y Zhang, J Yin, H Yan, L Yan, Y Li, C Zhang… - Frontiers in Cellular …, 2023 - frontiersin.org
Introduction Macrophages or T-lymphocytes triggered inflammation and, consequently,
activated glial cells may contribute to neuroinflammation and neurotransmitter dysfunction in …

IDH2/PPARγ pathway as a novel diagnostic biomarker panel for schizophrenia

K Xu, X Zhou, Y Ren, S Zhao, J Feng, H Zhang… - Asian Journal of …, 2023 - Elsevier
2. Methods The local ethics committee of Chongqing Medical University approved this study.
Each participant gave their written informed permission before collecting blood samples …

[HTML][HTML] Systematic review and meta-analysis of damage associated molecular patterns HMGB1 and S100B in schizophrenia

M Mackey, L Holleran, G Donohoe… - Psychiatry …, 2022 - ncbi.nlm.nih.gov
Objective Immune system dysregulation is hypothesised to be central to the
aetiopathogenesis of schizophrenia; however, the role of sterile inflammation remains …